Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.

Katapodi MC, Northouse L, Pierce P, Milliron KJ, Liu G, Merajver SD.

Oncol Nurs Forum. 2011 Sep;38(5):572-81. doi: 10.1188/11.ONF.572-581.

PMID:
21875844
2.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
3.
4.

Psychological adjustment among male partners in response to women's breast/ovarian cancer risk: a theoretical review of the literature.

Sherman KA, Kasparian NA, Mireskandari S.

Psychooncology. 2010 Jan;19(1):1-11. doi: 10.1002/pon.1582. Review.

PMID:
19472298
5.

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.

Kuschel B, Lux MP, Goecke TO, Beckmann MW.

Eur J Cancer Prev. 2000 Jun;9(3):139-50. Review.

PMID:
10954253
6.

Identifying and managing hereditary risk of breast and ovarian cancer.

Frank TS, Critchfield GC.

Clin Perinatol. 2001 Jun;28(2):395-406. Review.

PMID:
11499060
7.

[Cognitive, emotional and behavioral impact of an uncertain outcome after study of BRCA1/2: review of the literature].

Leblond D, Brédart A, Dolbeault S, De Pauw A, Stoppa Lyonnet D, Flahault C, Sultan S.

Bull Cancer. 2011 Feb;98(2):184-98. doi: 10.1684/bdc.2011.1309. Review. French.

8.

Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information.

Nycum G, Avard D, Knoppers BM.

Eur J Hum Genet. 2009 Jul;17(7):872-80. doi: 10.1038/ejhg.2009.33. Epub 2009 Mar 25. Review.

9.

Decision making and decision support for hereditary breast-ovarian cancer susceptibility.

Schwartz MD, Peshkin BN, Tercyak KP, Taylor KL, Valdimarsdottir H.

Health Psychol. 2005 Jul;24(4S):S78-84. Review.

PMID:
16045423
10.

A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.

Heshka JT, Palleschi C, Howley H, Wilson B, Wells PS.

Genet Med. 2008 Jan;10(1):19-32. doi: 10.1097/GIM.0b013e31815f524f. Review.

PMID:
18197053
11.

Evolution of the colored eco-genetic relationship map (CEGRM) for assessing social functioning in women in hereditary breast-ovarian (HBOC) families.

Peters JA, Hoskins L, Prindiville S, Kenen R, Greene MH.

J Genet Couns. 2006 Dec;15(6):477-89. Epub 2006 Nov 17. Review.

PMID:
17111216
12.

Men's decision-making about predictive BRCA1/2 testing: the role of family.

Hallowell N, Ardern-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C, Watson M.

J Genet Couns. 2005 Jun;14(3):207-17. Review.

PMID:
15959652
13.

[Psychosocial counseling after diagnosis for non-carriers of hereditary breast cancer or ovarian cancer; is it needed?].

van der Linden MH.

Ned Tijdschr Geneeskd. 2000 Dec 9;144(50):2381-4. Review. Dutch.

PMID:
11145091
14.

Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders.

Beery TA, Williams JK.

Genet Test. 2007 Summer;11(2):111-23. Review. Erratum in: Genet Test. 2007 Autumn;11(3):345.

PMID:
17627380
15.

Survivorship considerations in adults with hereditary breast and ovarian cancer syndrome: state of the science.

Crotser CB, Boehmke M.

J Cancer Surviv. 2009 Mar;3(1):21-42. doi: 10.1007/s11764-008-0077-7. Epub 2009 Jan 23. Review.

PMID:
19165605
16.

Psychiatric implications of cancer genetic testing.

Hirschberg AM, Chan-Smutko G, Pirl WF.

Cancer. 2015 Feb 1;121(3):341-60. doi: 10.1002/cncr.28879. Epub 2014 Sep 18. Review.

17.

Information processing in the context of genetic risk: implications for genetic-risk communication.

Etchegary H, Perrier C.

J Genet Couns. 2007 Aug;16(4):419-32. Epub 2007 May 1. Review.

PMID:
17473961
18.

Distress in unaffected individuals who decline, delay or remain ineligible for genetic testing for hereditary diseases: a systematic review.

Heiniger L, Butow PN, Price MA, Charles M.

Psychooncology. 2013 Sep;22(9):1930-45. doi: 10.1002/pon.3235. Epub 2012 Dec 12. Review.

PMID:
23233440
19.

Genetic counseling for hereditary breast and ovarian cancer among Puerto Rican women living in the United States.

Scherr CL, Vasquez E, Quinn GP, Vadaparampil ST.

Rev Recent Clin Trials. 2014;9(4):245-53. Review.

20.

Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers.

Vadaparampil ST, Ropka M, Stefanek ME.

Fam Cancer. 2005;4(2):195-206. Review.

PMID:
15951974

Supplemental Content

Support Center